Skip to main content
. 2022 May 18;12:837408. doi: 10.3389/fonc.2022.837408

Figure 5.

Figure 5

Anticancer activities of EGCG and quercetin. Epigallocatechin-3-gallate (EGCG) and quercetin modulate several canonical oncological pathways such as Wnt/β-catenin and JAK/STAT pathways. Also, they modulate the expression of several anti-apoptotic proteins such as BCL2, tumor suppressor proteins such as TP53, and oncogenic drivers such as VEGF. Both active ingredients have proven to be effective in halting the malignant transformation process in several types of cancers such as breast, lung, liver, and colorectal cancers.